🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: MET/VEGFR2 inhibitor Foretinib and erlotinib hydrochloride may s...
Status
Completed
Location
BCCA - Vancouver Cancer Centre
Start Date
2010-01-21
Trial ID
NCT01068587
Treatments Being Tested
Study to compare 2 different chemical forms of GSK1363089....
Status
Completed
Location
GSK Investigational Site
Start Date
2008-08-11
Trial ID
NCT00742261
Treatments Being Tested
This clinical study is being conducted at two sites to determine the optimu...
Status
Completed
Location
Multiple Locations
Start Date
2006-08-09
Trial ID
NCT00743067
Treatments Being Tested
This clinical study is being conducted at two sites to determine the optimu...
Status
Completed
Location
Multiple Locations
Start Date
2005-03-17
Trial ID
NCT00742131
Treatments Being Tested
This clinical study is being conducted at multiple sites to determine the b...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06-30
Trial ID
NCT00726323
Treatments Being Tested
This clinical study is being conducted at multiple sites to determine the b...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03-31
Trial ID
NCT00725712
Treatments Being Tested
Foretinib (GSK1363089) is an investigational, oral, multikinase inhibitor i...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02034097
The purpose of this study is to find out what effects this new drug foretin...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2010-09-02
Trial ID
NCT01147484
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of foret...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-12
Trial ID
NCT00920192
Treatments Being Tested
This research is being done because it is not yet known what dose of foreti...
Status
Completed
Location
BCCA - Cancer Centre for the Southern Interior
Start Date
2010-10-27
Trial ID
NCT01138384